XCE tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide demonstrates promising potential in metabolic disorder research, particularly in studies related to type 2 diabetes management and weight control.
The XCE tirzepatide compound works by simultaneously activating both GIP and GLP-1 receptors, which are important regulators of insulin secretion and glucose metabolism. Research suggests this dual mechanism may offer superior glycemic control compared to single-receptor agonists.
Our XCE tirzepatide is synthesized through advanced chemical processes and undergoes rigorous quality control testing to ensure 99% purity. The white powder form provides excellent stability and convenient handling for research applications.
Important Note: This XCE tirzepatide product is prepared by chemical synthesis and is intended for research purposes only. Not for human consumption or clinical use.
For optimal preservation of XCE tirzepatide:
When properly stored, XCE tirzepatide maintains stability for over 2 years. For research requiring solutions, we recommend preparing fresh aliquots as needed rather than storing long-term in solution.